Pancreatic Neoplasms: all 3,310 studies

Page 11 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.

• QUILT-3.080: NANT Pancreatic Cancer VaccineTerminatedNCT03586869Phase 1/2Results posted
• A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerCompletedNCT03535727Phase 1/2Results posted
• A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerTerminatedNCT03519308Early Phase 1Results posted
• A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic CancerTerminatedNCT03512756Phase 2/3Results posted
• Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaTerminatedNCT03469258Phase 2Results posted
• M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the PancreasTerminatedNCT03451773Phase 1/2Results posted
• Use of Epidurals Intraoperatively for Patients Undergoing Pancreas ResectionCompletedNCT03434678Phase 3Results posted
• Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)CompletedNCT03415854Phase 2Results posted
• Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal PancreatectomyCompletedNCT03410914Phase 2Results posted
• Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)CompletedNCT03410030Phase 1/2Results posted
• QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03387098Phase 1/2Results posted
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerCompletedNCT03362177Phase 3Results posted
• Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic CancerTerminatedNCT03344172Phase 2Results posted
• Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic CancerCompletedNCT03340974Phase 1/2Results posted
• A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic CancerCompletedNCT03336216Phase 2Results posted
• A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic CancerCompletedNCT03331562Phase 2Results posted
• QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03329248Phase 1/2Results posted
• Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic CancerCompletedNCT03310632Phase 1/2Results posted
• PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerCompletedNCT03304210Phase 1Results posted
• Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?CompletedNCT03269994Phase 3Results posted
• Azacitidine and Pembrolizumab in Pancreatic CancerCompletedNCT03264404Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsCompletedNCT03261947Phase 2Results posted
• A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic AdenocarcinomaCompletedNCT03250273Phase 2Results posted
• TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic CancerCompletedNCT03192462Phase 1/2Results posted
• Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic CancerCompletedNCT03190265Phase 2Results posted
• RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic CancerCompletedNCT03189914Phase 1/2Results posted
• Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic NeoplasmsCompletedNCT03188991Phase 2Results posted
• A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid TumorsCompletedNCT03184870Phase 1/2Results posted
• GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic CancerCompletedNCT03161379Phase 2Results posted
• Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
• Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based TherapyTerminatedNCT03140670Phase 2Results posted
• QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyTerminatedNCT03136406Phase 1/2Results posted
• QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
• EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOXCompletedNCT03126435Phase 3Results posted
• Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant ChemotherapyTerminatedNCT03122106Phase 1Results posted
• Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerCompletedNCT03095781Phase 1Results posted
• APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by SurgeryCompletedNCT03087591Phase 1Results posted
• A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic CancerCompletedNCT03086369Phase 1/2Results posted
• Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine TumorsCompletedNCT03043664Phase 1/2Results posted
• FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasTerminatedNCT03042780Phase 2Results posted
• Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R MutationsCompletedNCT03040986Phase 2Results posted
• Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 StudyCompletedNCT03033225Phase 2Results posted
• Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic CancerCompletedNCT03023722Phase 2Results posted
• Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site InfectionsCompletedNCT03021668Not applicableResults posted
• Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas CancerCompletedNCT03006302Phase 2Results posted
• A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid TumorsCompletedNCT02999672Phase 2Results posted
• PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic CancerTerminatedNCT02985801Phase 1/2Results posted
• Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal MalignanciesTerminatedNCT02950025Phase 2Results posted
• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerCompletedNCT02923921Phase 3Results posted
• Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT02907099Phase 2Results posted
• A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)CompletedNCT02905578Phase 2Results posted
• Study of Nintedanib and Chemotherapy for Advanced Pancreatic CancerTerminatedNCT02902484Phase 1/2Results posted
• Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT02896907Early Phase 1Results posted
• FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT02890355Phase 2Results posted
• A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic CancerCompletedNCT02873598Phase 1Results posted
• FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + GemcitabineCompletedNCT02827201Phase 2Results posted
• Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsCompletedNCT02810418Phase 1/2Results posted
• Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesCompletedNCT02807844Phase 1/2Results posted
• Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary RegionCompletedNCT02780648Not applicableResults posted
• Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic CancerCompletedNCT02775695Phase 2Results posted
• Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular CorrelatesCompletedNCT02723331Phase 2Results posted
• Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor CancerCompletedNCT02713529Phase 1/2Results posted
• Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesTerminatedNCT02711137Phase 1/2Results posted
• SBRT Plus Pembrolizumab and Trametinib for Pancreatic CancerCompletedNCT02704156Phase 2Results posted
• Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic CancerCompletedNCT02704143Not applicableResults posted
• A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic CancerCompletedNCT02694536Phase 3Results posted
• Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork NeedleCompletedNCT02678442Not applicableResults posted
• Olaparib in Treating Patients With Stage IV Pancreatic CancerCompletedNCT02677038Phase 2Results posted
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTerminatedNCT02669914Phase 2Results posted
• Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mgCompletedNCT02651987Phase 2Results posted
• BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer PatientsCompletedNCT02650804Phase 2Results posted
• Preoperative Exercise in Pancreatic CancerCompletedNCT02648880Not applicableResults posted
• Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02648282Phase 2Results posted
• BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic CancerCompletedNCT02620865Phase 1/2Results posted
• BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic CancerTerminatedNCT02608229Phase 1Results posted
• Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic CancerCompletedNCT02581215Phase 2Results posted
• FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialCompletedNCT02578732Phase 2Results posted
• Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic CancerTerminatedNCT02570711Phase 2Results posted
• S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02562716Phase 2Results posted
• Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaCompletedNCT02551991Phase 2Results posted
• Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic CancerCompletedNCT02517268Not applicableResults posted
• Stereotactic Body Radiotherapy Dose Escalation in Pancreatic CancerCompletedNCT02454140Not applicableResults posted
• Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02427841Phase 2Results posted
• A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT02403271Phase 1/2Results posted
• A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic TumoursCompletedNCT02402062Phase 2Results posted
• A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic CancerCompletedNCT02395016Phase 3Results posted
• Improving Goals of Care Discussion in Advanced Cancer PatientsCompletedNCT02374255Not applicableResults posted
• ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic CancerCompletedNCT02362048Phase 2Results posted
• Tosedostat With Capecitabine in Patients With Metastatic Pancreatic AdenocarcinomaTerminatedNCT02352831Phase 1/2Results posted
• First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus FirgemCompletedNCT02352337Phase 2Results posted
• Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyTerminatedNCT02345460Phase 2Results posted
• KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic CancerCompletedNCT02337465Not applicableResults posted
• Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.CompletedNCT02332863Not applicableResults posted
• Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic CancerCompletedNCT02318095Not applicableResults posted
• Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic CancerCompletedNCT02311361Phase 1/2Results posted
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT02301143Phase 2Results posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Improving Informed Consent for Palliative ChemotherapyCompletedNCT02282722Not applicableResults posted
• Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerTerminatedNCT02273752Phase 2Results posted
• Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic CancerCompletedNCT02261714Phase 1/2Results posted

← Pancreatic Neoplasms overview